On April 9, 2024, Biotricity, Inc. closed the transaction. The company announced that it has issued 110 shares of Series B Convertible Preferred Stock at an issue price of $9,090.91 per share for the gross proceeds of $1,000,000.1 in the second and final tranche. The minimum investment from an outsider is $1,000,000 and included participation from single investor.